Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01209234 · ClinicalTrials.gov registry record · NA
Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 2,140
- Enrollment target
NCT01209234 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 2,140 participants.
The verdict
NCT01209234, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,140 participants
- Enrollment target
Study Summary
This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.
Interventions
- BEHAVIORAL Standard-of-Care Education
- DRUG MRSA Decolonization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,140 participants |
| Start Date | 2011-01 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01209234
The ClinicalTrials.gov registry entry for NCT01209234 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard-of-Care Education is the first listed.
NCT01209234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01209234 about?
NCT01209234 is a clinical study titled "Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance". This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventi...
What is the current status of trial NCT01209234?
This trial is currently completed. It is a NA study. The enrollment target is 2,140 participants. The study started on 2011-01. Estimated completion is 2019-01.
What interventions are being tested in trial NCT01209234?
The interventions under investigation include: Standard-of-Care Education (BEHAVIORAL), MRSA Decolonization (DRUG).
Who is sponsoring clinical trial NCT01209234?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.